Section one: Contracting authority
one.1) Name and addresses
NHS England
1st Floor, Quarry House, Quarry Hill
Leeds
LS2 7UE
Contact
Mary-Jo Pryor
Country
United Kingdom
Region code
UKE - Yorkshire and the Humber
Internet address(es)
Main address
Buyer's address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
https://health-family.force.com/s/Welcome
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
https://health-family.force.com/s/Welcome
Tenders or requests to participate must be submitted to the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
NHS Framework Agreement for the supply of Ranibizumab for the NHS in England
Reference number
C123966
two.1.2) Main CPV code
- 33690000 - Various medicinal products
two.1.3) Type of contract
Supplies
two.1.4) Short description
The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England.
Anti Veg-F medicines are currently used in the treatment of:
a. neovascular (wet) age-related macular degeneration (AMD);
b. visual impairment due to diabetic macular oedema (DME/DMO);
c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and
d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).
two.1.5) Estimated total value
Value excluding VAT: £120,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 33600000 - Pharmaceutical products
two.2.3) Place of performance
NUTS codes
- UKE - Yorkshire and the Humber
Main site or place of performance
NHS England
two.2.4) Description of the procurement
The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England.
Anti Veg-F medicines are currently used in the treatment of:
a. neovascular (wet) age-related macular degeneration (AMD);
b. visual impairment due to diabetic macular oedema (DME/DMO);
c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and
d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £120,000,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Start date
1 April 2023
End date
31 March 2024
This contract is subject to renewal
Yes
Description of renewals
An option to extend for a further period of 12 months. i.e. the total possible framework agreement duration is 24 months.
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
four.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
Framework agreement with several operators
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: No
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
10 February 2023
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until: 1 May 2023
four.2.7) Conditions for opening of tenders
Date
10 February 2023
Local time
5:00pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: Yes
Estimated timing for further notices to be published: 8 months
six.4) Procedures for review
six.4.1) Review body
NHS England
Quarry House, Quarry Hill
Leeds
LS2 7UE
Country
United Kingdom